ABB invests $280 million in new robotics factory in Sweden
ABB, whose products range from industrial motors and drives, to chargers for electric vehicles, will build the new factory at its site in Vasteras, eastern Sweden.13-09-2023
ABB invests $280 million in new robotics factory in Sweden
ABB, whose products range from industrial motors and drives, to chargers for electric vehicles, will build the new factory at its site in Vasteras, eastern Sweden.ABB stock had a stellar run, but there may be speed breakers ahead
In Q2 2023, ABB's order inflows rose 10% year-on-year to 3,044 crore despite a high base, and order book stood at 7,727 crore.ABB India Limited - 500002 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Tata Steel and ABB will jointly explore technologies to help reduce carbon footprint of steel productionABB India Limited - 500002 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Analyst call held on August 28, 2023ABB India Limited - 500002 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificateABB India Limited - 500002 - Disclosure Under The Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Amendments Thereto ('Listing Regulations')
Disclosure under the Regulation 30 of the SEBI (LODR) Regulation and amendments theretoABB India Limited - 500002 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
video recording of Analysts/ Investor Call held on Monday, August 28, 2023ABB India Limited - 500002 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificateABB India Limited - 500002 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of virtual meeting with analyst/ investors on Monday, August 28, 2023ABB India to automate Reliance Life Sciences' biopharmaceutical facilities
The 160-acre Nashik facility will house manufacturing plants for plasma proteins, biopharmaceuticals, oncology pharmaceuticals and vaccines